Sabolic Ivan, Ljubojevic Marija, Herak-Kramberger Carol M, Brown Dennis
Unit of Molecular Toxicology, Institute for Medical Research and Occupational Health, 10001 Zagreb, Croatia.
Am J Physiol Renal Physiol. 2002 Dec;283(6):F1389-402. doi: 10.1152/ajprenal.00066.2002.
Nephrotoxicity in humans and experimental animals due to chronic exposure to cadmium (Cd) is manifested by defects in the reabsorptive and secretory functions of proximal tubules (PT). The main symptoms of Cd nephrotoxicity, including polyuria, phosphaturia, aminoaciduria, glucosuria, and proteinuria, suggest that various brush-border membrane (BBM) transporters are the main targets of Cd. Specific transporters may be either directly inhibited by Cd or lost from the BBM after Cd treatment, or both. We have recently proposed that Cd may impair the vesicle-dependent recycling of BBM transporters by inhibiting vacuolar H+-ATPase (V-ATPase) activity and endocytosis in PT cells (Herak-Kramberger CM, Sabolic I, and Brown D. Kidney Int 53: 1713-1726, 1998). The mechanism underlying the Cd effect was further explored in an in vivo model of experimental Cd nephrotoxicity induced by Cd-metallothionein (Cd-MT; 0.4 mg Cd/kg body mass; a single dose sc) in rats. The time-dependent redistribution of various BBM transporters was examined in this model by fluorescence and gold-labeling immunocytochemistry on tissue sections and by immunoblotting of isolated renal cortical BBM. In PT cells of Cd-MT-treated rats, we observed 1) shortening and loss of microvilli; 2) time-dependent loss of megalin, V-ATPase, aquaporin-1 (AQP1), and type 3 Na+/H+ exchanger (NHE3) from the BBM; 3) redistribution of these transporters into vesicles that were randomly scattered throughout the cell cytoplasm; and 4) redistribution of NHE3, but not megalin, into the basolateral plasma membrane. The internalization of BBM transporters was accompanied by fragmentation and loss of microtubules and by an increased abundance of alpha-tubulin monomers in PT cells. Transporter redistribution was detectable as early as 1 h after Cd-MT treatment and increased in magnitude over the next 12 h. We conclude that the early mechanism of Cd toxicity in PT cells may include a colchicine-like depolymerization of microtubules and impaired vesicle-dependent recycling of various BBM proteins. These processes may lead to a time-dependent loss of cell membrane components, resulting in reabsorptive and secretory defects that occur in Cd-induced nephrotoxicity.
人类和实验动物因长期接触镉(Cd)而导致的肾毒性表现为近端小管(PT)重吸收和分泌功能的缺陷。Cd肾毒性的主要症状,包括多尿、磷酸盐尿、氨基酸尿、糖尿和蛋白尿,表明各种刷状缘膜(BBM)转运蛋白是Cd的主要作用靶点。特定的转运蛋白可能被Cd直接抑制,或在Cd处理后从BBM丢失,或两者皆有。我们最近提出,Cd可能通过抑制PT细胞中的液泡H⁺-ATP酶(V-ATP酶)活性和内吞作用,损害BBM转运蛋白的囊泡依赖性再循环(Herak-Kramberger CM、Sabolic I和Brown D. Kidney Int 53: 1713 - 1726, 1998)。在大鼠体内由镉-金属硫蛋白(Cd-MT;0.4 mg Cd/kg体重;单次皮下注射)诱导的实验性Cd肾毒性模型中,进一步探讨了Cd作用的潜在机制。通过对组织切片进行荧光和金标免疫细胞化学以及对分离的肾皮质BBM进行免疫印迹,在该模型中检测各种BBM转运蛋白的时间依赖性重新分布。在Cd-MT处理的大鼠的PT细胞中,我们观察到:1)微绒毛缩短和丢失;2)BBM中巨蛋白、V-ATP酶、水通道蛋白-1(AQP1)和3型Na⁺/H⁺交换体(NHE3)随时间丢失;3)这些转运蛋白重新分布到随机散布在整个细胞质中的囊泡中;4)NHE3重新分布到基底外侧质膜中,但巨蛋白没有。BBM转运蛋白的内化伴随着微管的断裂和丢失以及PT细胞中α-微管蛋白单体丰度的增加。转运蛋白重新分布在Cd-MT处理后1小时即可检测到,并在接下来的12小时内幅度增加。我们得出结论,PT细胞中Cd毒性的早期机制可能包括微管的秋水仙碱样解聚和各种BBM蛋白的囊泡依赖性再循环受损。这些过程可能导致细胞膜成分随时间丢失,从而导致Cd诱导的肾毒性中出现的重吸收和分泌缺陷。